PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
184406-4	1976	Norgestrel reduced TeBG binding capacity but not CBG binding capacity.	Norgestrel	0-10	sex hormone binding globulin	Homo sapiens	19-23	
184406-5	1976	Norgestrel competitively inhibited the binding of dihydrotestosterone to TeBG under in vitro conditions.	Norgestrel	0-10	sex hormone binding globulin	Homo sapiens	73-77	
6540031-0	1984	Effects of two estradiol/norgestrel combinations on the ovulatory pattern and on sex hormone binding globulin capacity in women around forty years of age.	Norgestrel	25-35	sex hormone binding globulin	Homo sapiens	81-109	
7195405-4	1981	Computer simulation predicted that by interacting with TeBG, therapeutic levels of danazol, methyltestosterone, fluoxymesterone, and norgestrel could displace 83%, 48%, 43%, and 16%, respectively, of the concentration of testosterone bound to TeBG in a normal man.	Norgestrel	133-143	sex hormone binding globulin	Homo sapiens	55-59	
7195405-4	1981	Computer simulation predicted that by interacting with TeBG, therapeutic levels of danazol, methyltestosterone, fluoxymesterone, and norgestrel could displace 83%, 48%, 43%, and 16%, respectively, of the concentration of testosterone bound to TeBG in a normal man.	Norgestrel	133-143	sex hormone binding globulin	Homo sapiens	243-247	
31689504-5	2020	Protein-ligand complexes, involving dimeric SHBG saturated with two ligands on each subunit, reproduce the experimental affinity tendency and allow the observation that dimerization exerts disparate effects on binding affinity, characteristic of negative cooperativity for E2, DHT, and NOG, whereas 3beta-17alpha-diol and 3beta-17beta-diol lack allostery.	Norgestrel	286-289	sex hormone binding globulin	Homo sapiens	44-48